Work

Mega‐dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II study

Year: 2024

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.19781

Authors: Meng Lv, Chen‐Hua Yan, Rui Ma, Yun He, Yuan‐Yuan Zhang, Zhi‐Dong Wang, Yu‐Hong Chen, Wei Han, Jun Kong, Ting‐Ting Han, Jing Liu, Hao Zheng, Xiao‐Dong Mo, Yu‐Qian Sun, Yu Wang, Lan‐Ping Xu, Xiao‐Hui Zhang, Xiao‐Jun Huang

Institutions: Peking University People's Hospital, Peking University, Center for Life Sciences, State Key Laboratory of Natural and Biomimetic Drugs

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Peking University, Beijing Nova Program, National Key Research and Development Program of China

Awards: 白血病干细胞免疫逃逸及其机制研究, G382933768, G3949111090, G4282754715, G433997454, 造血干细胞移植后出血性膀胱炎免疫损伤机制及其干预研究, G5866533980

OpenAlex ID: W4402936412

FWCI: 0.534

Cites: 55

Cited by: 2

Related to: 10